about
Ultrastructural fingerprints of avian influenza A (H7N9) virus in infected human lung cells.Cold oxygen plasma technology efficiency against different airborne respiratory viruses.Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response.Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication.Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α.Critical role of segment-specific packaging signals in genetic reassortment of influenza A virusesViral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study.Influenza viruses and mRNA splicing: doing more with lessMutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia.The NS1 Protein from Influenza Virus Stimulates Translation Initiation by Enhancing Ribosome Recruitment to mRNAs.Influenza NS1 interacts with p53 and alters its binding to p53-responsive genes, in a promoter-dependent manner.Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein.The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses.The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses.Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles.In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance?Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach.Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants.Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3.RSV Infection in Human Macrophages Promotes CXCL10/IP-10 Expression during Bacterial Co-Infection.Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection.Role of p53/NF-κB functional balance in respiratory syncytial virus-induced inflammation responseRepurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection SignaturesDrug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy[A novel mechanism for virally-induced hijacking of p53 identified in the context of influenza virus infection]Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine DevelopmentThe Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epitheliaTranscriptional profiling of immune and inflammatory responses in the context of SARS-CoV-2 fungal superinfection in a human airway epithelial modelCharacterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epitheliaBroad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus
P50
Q30363150-48E92610-81DA-4EDC-B2BE-B57659BA1FBEQ30376654-0EB07468-3996-420D-A779-12515E35A6DBQ30561763-2AB28319-D7C6-4578-9C44-0AC126DEE719Q34047120-9DC42025-7F0F-400F-856F-A19550CC805EQ36172140-1A2E22E1-71BF-4A04-8317-B8F023FF8684Q37218430-43450985-BA55-4825-A14B-0BFDF5045C67Q37475814-88552D1B-D345-4B9A-AA8D-9FD54C7848A8Q38211561-DA0E07B0-5BD0-4707-9095-5010373083FCQ38700391-D33E7861-B305-4700-A152-B0A8BF5AC7C8Q38824998-FF70EE3C-C6A5-4A72-9130-AD541388BC8BQ39109027-4EB9A51E-3D7C-49EA-9185-52DCC6F990E6Q39142106-3F8215FA-656E-48EC-ACEF-9C9B499B419EQ39318453-BD9877E3-8757-450F-B5EC-9D1140F5478FQ39455183-792CE044-28E5-4B64-9B0E-98AD0C9C7B84Q39563269-60277833-8D7B-44F4-A24B-BB4F156C70E5Q39680790-FFB5B827-3677-45D8-98AC-1BAAF1C91BE9Q39796858-4E98D73D-355B-4B3C-A472-5B27D5F41BC3Q39968287-E2F32C29-7C6F-4957-BEFB-F3D3332E6995Q44356265-20D073B6-F36F-4277-8843-4FA998C9C89BQ47189394-BC2006C3-2348-4A2A-A5D7-8A8E9246552BQ50356107-5A62AAD6-7CDC-48EB-BE5A-E46CB6956825Q59350603-5265DE7E-1EB6-4A57-8CE8-374765D9F8F2Q61807025-EDD92A4D-12A5-4D1D-9F69-9B33B40DD833Q63246314-7055225F-A0D3-456A-87D6-C8B8B233736FQ90028938-37CAE738-A051-4F48-8EB4-0AD6F31AACA2Q91037731-F4436B76-849A-4019-9241-34E701AE6040Q91080394-699496A1-09EB-44D3-8AB2-BC5B578F7758Q92483517-D44BFCEB-484D-4037-8321-43E88BEC5F2EQ95601295-FC242552-0E53-4FB5-9170-89D8A2039449Q95606227-0DE501E8-1707-4F09-84B6-E2CF3C696B95Q95607999-D4A23423-4256-4C3F-93FC-744DFFAAB34D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Olivier Terrier
@ast
Olivier Terrier
@en
Olivier Terrier
@es
Olivier Terrier
@nl
Olivier Terrier
@sl
type
label
Olivier Terrier
@ast
Olivier Terrier
@en
Olivier Terrier
@es
Olivier Terrier
@nl
Olivier Terrier
@sl
prefLabel
Olivier Terrier
@ast
Olivier Terrier
@en
Olivier Terrier
@es
Olivier Terrier
@nl
Olivier Terrier
@sl
P106
P1153
23994742900
P31
P496
0000-0001-9393-7684